Scott Dunseth Myers, Chief Executive Officer at Viridian Therapeutics, Inc.\DE (VRDN), bought 5,500 shares at $29.15 ($160K) on 2023-03-13, disclosed to the SEC on 2023-03-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| VRDN | BUY | 2023-04-12 | $101K | — | Filing → |
| CASC | BUY | 2017-08-14 | $21K | — | Filing → |
| CASC | BUY | 2017-05-16 | $11K | — | Filing → |